Lung Cancer Surgery

Clinical Services: Cardiothoracic Surgery (Thoracic Surgery)
Upper East Side
525 East 68th Street, M-404
New York, NY 10065
Mon-Fri 09:00am - 05:00pm
(646) 962-0203
(212) 746-5166
Northwest Brooklyn
263 7th Avenue, Suite 4H
Brooklyn, NY 11215
Mon-Fri 09:00am - 05:00pm
(718) 780-6701
(718) 780-7700
North Queens
56-45 Main Street, Suite WA100
Flushing, NY 11355
Mon-Fri 09:00am - 05:00pm
(718) 670-2762
(718) 780-2707
Southern Brooklyn
2625 East 14th Street, Suite 201
Brooklyn, NY 11235
(646) 962-0203
(855) 379-3125

Surgery to remove tumorous tissue is the most effective treatment for early stage non-small cell lung cancer (NSCLC). The procedure may involve removing a section of a lung or an entire lung, depending on the size and location of a tumor.

Until recently, the standard approach for the surgical treatment for lung cancer was “open surgery,” which included a large incision that spreads the ribs (thoracotomy). This technique is associated with postoperative pain and lung complications, including pneumonia.

Minimally invasive surgical options

At Weill Cornell, we use minimally invasive surgical approaches in 90% of patients—such as video-assisted thoracoscopy (VATS) or robotic techniques—for patients with operable lung cancer.

Thoracoscopic lobectomy (VATS): Telescopes placed through small incisions in the chest and abdomen are used to visualize the lung, and small instruments are passed between the rib spaces to manipulate and remove the lobe.

After a thoracoscopic lobectomy, most patients need to stay in the hospital for only two to three days. They typically achieve improved breathing function earlier than they would have following open surgery, as a result of this less invasive and less painful procedure. Patients who have thoracoscopic lobectomy also usually require fewer pain medications than those who have traditional, “open” surgery.

Lung cancer surgery expertise at Weill Cornell Medicine

Our patients benefit from:

• The most advanced techniques in surgical procedures including robotics, which enables greater magnification and more precision

• Access to state of the art genetic testing of patient tumor to determine best approach for further treatment if necessary

• Access to the latest clinical trials for all stages of cancer condition

• Multi-disciplinary approach (collaboration among surgeons, oncologists, radiologists, gastroenterologists, and pathologists) tailored to the unique needs of each patient